Journal
TRENDS IN CELL BIOLOGY
Volume 12, Issue 5, Pages 209-211Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0962-8924(02)02280-8
Keywords
-
Categories
Ask authors/readers for more resources
Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available